Oral availability and brain penetration of the B-RAFV600E inhibitor vemurafenib can be enhanced by the P-GLYCOprotein (ABCB1) and breast cancer resistance protein (ABCG2) inhibitor elacridar (Q44225787)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Oral availability and brain penetration of the B-RAFV600E inhibitor vemurafenib can be enhanced by the P-GLYCOprotein (ABCB1) and breast cancer resistance protein (ABCG2) inhibitor elacridar |
scientific article |
Statements
1 reference
Oral availability and brain penetration of the B-RAFV600E inhibitor vemurafenib can be enhanced by the P-GLYCOprotein (ABCB1) and breast cancer resistance protein (ABCG2) inhibitor elacridar (English)
1 reference
1 reference
Jos H Beijnen
1 reference
Alfred H Schinkel
1 reference
Rolf W Sparidans
1 reference
Els Wagenaar
1 reference
18 October 2012
1 reference
1 reference
9
1 reference
11
1 reference
3236-3245
1 reference
Identifiers
1 reference
1 reference